Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Cytoplasmic and Nuclear | 7 | 2025 | 323 | 1.180 |
Why?
|
| Kupffer Cells | 2 | 2020 | 20 | 0.800 |
Why?
|
| Receptors, Calcitriol | 2 | 2020 | 61 | 0.780 |
Why?
|
| Hepatitis | 2 | 2020 | 58 | 0.660 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2009 | 145 | 0.570 |
Why?
|
| Liver | 8 | 2025 | 1797 | 0.560 |
Why?
|
| Insulin Resistance | 2 | 2020 | 697 | 0.470 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 417 | 0.440 |
Why?
|
| beta Catenin | 1 | 2015 | 225 | 0.410 |
Why?
|
| Carcinogenesis | 1 | 2015 | 358 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 500 | 0.350 |
Why?
|
| RNA Helicases | 2 | 2022 | 69 | 0.340 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2022 | 94 | 0.330 |
Why?
|
| Receptors, Steroid | 1 | 2009 | 176 | 0.290 |
Why?
|
| Fatty Liver | 1 | 2009 | 211 | 0.270 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2018 | 70 | 0.260 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 138 | 0.250 |
Why?
|
| Hymecromone | 1 | 2025 | 10 | 0.240 |
Why?
|
| Drug Repositioning | 1 | 2025 | 31 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 200 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 4757 | 0.230 |
Why?
|
| Mice | 15 | 2025 | 18507 | 0.230 |
Why?
|
| Diet, High-Protein | 1 | 2024 | 5 | 0.210 |
Why?
|
| Hepatocytes | 4 | 2020 | 237 | 0.210 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 18 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 341 | 0.210 |
Why?
|
| Animals | 16 | 2025 | 34881 | 0.200 |
Why?
|
| Prostatic Neoplasms | 2 | 2022 | 1539 | 0.190 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 46 | 0.190 |
Why?
|
| Receptors, Androgen | 2 | 2022 | 409 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4688 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 861 | 0.170 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 1 | 2019 | 10 | 0.160 |
Why?
|
| Copper-transporting ATPases | 1 | 2020 | 27 | 0.160 |
Why?
|
| Macrophage Activation | 1 | 2020 | 65 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 379 | 0.160 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2020 | 36 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 309 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 346 | 0.150 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 126 | 0.150 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 270 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2025 | 898 | 0.140 |
Why?
|
| Vitamin D | 1 | 2020 | 183 | 0.140 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 4 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2022 | 2057 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 136 | 0.140 |
Why?
|
| Retroviridae | 1 | 2017 | 193 | 0.130 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 758 | 0.120 |
Why?
|
| Aldehydes | 1 | 2015 | 31 | 0.120 |
Why?
|
| Inflammation | 2 | 2020 | 1517 | 0.120 |
Why?
|
| Bile Acids and Salts | 2 | 2009 | 255 | 0.120 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2015 | 50 | 0.120 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 100 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2020 | 3863 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 435 | 0.110 |
Why?
|
| Mitochondria | 1 | 2019 | 747 | 0.110 |
Why?
|
| Quinazolines | 1 | 2015 | 176 | 0.110 |
Why?
|
| Cellular Senescence | 1 | 2015 | 199 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 3681 | 0.100 |
Why?
|
| Male | 9 | 2025 | 64920 | 0.090 |
Why?
|
| o-Aminoazotoluene | 1 | 2011 | 1 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 605 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 763 | 0.080 |
Why?
|
| Diabetic Nephropathies | 1 | 2011 | 115 | 0.080 |
Why?
|
| Mice, SCID | 2 | 2022 | 601 | 0.080 |
Why?
|
| Sulfotransferases | 1 | 2009 | 25 | 0.080 |
Why?
|
| Mice, Obese | 1 | 2009 | 76 | 0.080 |
Why?
|
| Inactivation, Metabolic | 1 | 2009 | 28 | 0.080 |
Why?
|
| Self Care | 1 | 2011 | 226 | 0.080 |
Why?
|
| Lipogenesis | 1 | 2009 | 60 | 0.080 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 207 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2648 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 2438 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 2955 | 0.070 |
Why?
|
| Obesity | 1 | 2020 | 2391 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 175 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 459 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1882 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1610 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2023 | 4703 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1977 | 0.060 |
Why?
|
| Humans | 13 | 2025 | 132061 | 0.060 |
Why?
|
| Liver Regeneration | 1 | 2006 | 39 | 0.060 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 94 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 985 | 0.060 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2025 | 27 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1824 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2009 | 1123 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 896 | 0.060 |
Why?
|
| Insulin | 1 | 2009 | 1168 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2025 | 108 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1381 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2024 | 268 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2024 | 167 | 0.050 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 131 | 0.050 |
Why?
|
| Mutation | 1 | 2015 | 6229 | 0.040 |
Why?
|
| Androgens | 1 | 2022 | 277 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 254 | 0.040 |
Why?
|
| S-Adenosylmethionine | 1 | 2019 | 28 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 65 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2445 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 445 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 163 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2022 | 990 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 799 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2020 | 433 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 811 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 207 | 0.030 |
Why?
|
| Oncogenes | 1 | 2018 | 175 | 0.030 |
Why?
|
| Metabolome | 1 | 2020 | 325 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2006 | 2493 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 241 | 0.030 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2015 | 9 | 0.030 |
Why?
|
| Imines | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2015 | 11 | 0.030 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2015 | 14 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 878 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 526 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2015 | 223 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 322 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 719 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2015 | 292 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2011 | 2674 | 0.020 |
Why?
|
| Female | 4 | 2022 | 70710 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1347 | 0.020 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Metabolomics | 1 | 2015 | 480 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2011 | 21 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 40 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 451 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 472 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1538 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2006 | 8 | 0.020 |
Why?
|
| Cholestyramine Resin | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cholic Acid | 1 | 2006 | 19 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2006 | 34 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 1247 | 0.020 |
Why?
|
| Genes, myc | 1 | 2006 | 103 | 0.020 |
Why?
|
| Growth Substances | 1 | 2006 | 109 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 233 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2006 | 119 | 0.010 |
Why?
|
| DNA Replication | 1 | 2006 | 353 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2508 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 381 | 0.010 |
Why?
|
| Homeostasis | 1 | 2006 | 721 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 1358 | 0.010 |
Why?
|
| Diet | 1 | 2006 | 1124 | 0.010 |
Why?
|